News and Announcements
EDITORIAL
Immunomodulation and antitumor strategies targeting tumor microenvironment
Show Less
1
SH HO Urology Centre, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong,
China
MI, 4359 https://doi.org/10.36922/mi.4359
Submitted: 29 July 2024 | Published: 20 November 2024
(This article belongs to the Special Issue Immunomodulation and Antitumor Strategies in the Tumor Microenvironment )
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Conflict of interest
Xiaobo Wu is the editorial board member of this journal and the guest editor of this special issue. The author declared that he has no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
References
- Rashid K, Ahmad A, Meerasa SS, et al. Cancer stem cell-derived exosome-induced metastatic cancer: An orchestra within the tumor microenvironment. Biochimie. 2023;212: 1-11. doi: 10.1016/j.biochi.2023.03.014
- Park J, Hsueh PC, Li Z, Ho PC. Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity. Immunity. 2023;56(1):32-42. doi: 10.1016/j.immuni.2022.12.008
- Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell. 2023;41(3):450-465. doi: 10.1016/j.ccell.2023.02.014
- Zwergel C, Fioravanti R, Mai A. PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy? Drug Discov Today. 2023;28(2):103435. doi: 10.1016/j.drudis.2022.103435